The DOI matches its Crossref record; 234 of the 236 references it cites were found in a registry or an index.
p21 in cancer: intricate networks and multiple activities
Open accessAbstract
One of the main engines that drives cellular transformation is the loss of proper control of the mammalian cell cycle. The cyclin-dependent kinase inhibitor p21 (also known as p21WAF1/Cip1) promotes cell cycle arrest in response to many stimuli. It is well positioned to function as both a sensor and an effector of multiple anti-proliferative signals. This Review focuses on recent advances in our understanding of the regulation of p21 and its biological functions with emphasis on its p53-independent tumour suppressor activities and paradoxical tumour-promoting activities, and their implications in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“p21 is a potent cell-cycle inhibitor (39)”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [39]
In the citing paper
“CDKN1A (p21, WAF1, CIP1) was among the first p53 target genes11, 12 to be identified and is now recognized as an encoder for a major cell cycle checkpoint control protein.145”
From Census and evaluation of p53 target genes (2017) · cites this paper as [145]
In the citing paper
“As p21 is rarely genetically affected in cancers [1,124]”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [1]
In the citing paper
“Members of the Krüppel-like factor (KLF) transcription factor (TF) family can activate the CDKN1A gene by cooperating with p300-CREBBP (Aliouat-Denis et al., 2005; Abbas and Dutta, 2009).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Abbas and Dutta, 2009
In the citing paper
“p21WAF1/CIP1 can also be activated by p53 independent mechanisms by other stimulators such as nuclear receptors including androgen, vitamin D and retinoid receptors.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Abbas and Dutta, 2009
In the citing paper
“Although this is the first detectable event, it is more likely that main role of p21 lies in its capacity to trigger pRb-mediated repression of cell cycle regulators (Fig. 2, for more information on p21 functions (see ref. 98 ).”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [98]
In the citing paper
“For example, cyclin-dependent kinase inhibitor 1A (CDKN1A), a tumor suppressor that is downregulated in multiple cancers (106), is targeted by at least 28 miRNAs and many of which are upregulated together in cancers where CDKN1A has been implicated (107).”
From Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation (2018) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 1×
“CDK1, at least in some tissues, may be the crucial target of p21 in tumorigenesi”
BackgroundRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Xu, X., Yuan, G., Li, Q., Shan, S.-L., & Jiang, S. (2012) · Hepatogastroenterology · doi:10.5754/hge12404 · Cited by 1,825
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“Recent work suggests that tumour regression can be achieved through the reactivation of senescence, for example by restoring p53 functio”
BackgroundPCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
Flagged first, then by citations
2 of the 236 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Martin-Caballero, J., Flores, J. M., Garcia-Palencia, P. & Serrano, M. Tumor susceptibility of p21Waf1/Cip1-deficient mice. Cancer Res. 61, 6234–6238 (2001). This study demonstrates that deletion of Cdkn1a in mice results in spontaneous tumours but with late onset.
Cited by
Sorted by citations
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395
Cell cycle regulation: p53-p21-RB signaling
Engeland, K. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00988-z · Cited by 1,367
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
Karimian, A., Ahmadi, Y., & Yousefi, B. (2016) · DNA Repair · doi:10.1016/j.dnarep.2016.04.008 · Cited by 1,110
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova‐Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,051
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
The tumor suppressor protein p53 and the ferroptosis network
Kang, R., Kroemer, G., & Tang, D. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.074 · Cited by 714
Spencer, S. L., Cappell, S. D., Tsai, F., Overton, K. W., Wang, C. L., & Meyer, T. (2013) · Cell · doi:10.1016/j.cell.2013.08.062 · Cited by 673
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
Engeland, K. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.172 · Cited by 679
Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and Mutagenesis
Mohrin, M., Bourke, E., Alexander, D., Warr, M. R., Barry-Holson, K., Le Beau, M. M., Morrison, C. G., & Passegué, E. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.014 · Cited by 599
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2013) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 594
Chronic and Acute Toxicities of Aflatoxins: Mechanisms of Action
Benkerroum, N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020423 · Cited by 591
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Tarangelo, A., Magtanong, L., Bieging-Rolett, K. T., Li, Y., Ye, J., Attardi, L. D., & Dixon, S. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.077 · Cited by 570
Sp1 and the ‘hallmarks of cancer’
Beishline, K., & Azizkhan‐Clifford, J. (2014) · FEBS Journal · doi:10.1111/febs.13148 · Cited by 541
Evaluation of the use of therapeutic peptides for cancer treatment
Marqus, S., Pirogova, E., & Piva, T. J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0328-x · Cited by 522
p21: a two-faced genome guardian.
Georgakilas, A. G., Martin, O. A., & Bonner, W. M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.001 · Cited by 489
Lim, S., Janzer, A., Becker, A., Zimmer, A., Schüle, R., Buettner, R., & Kirfel, J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp324 · Cited by 472
Jeong, S. M., Xiao, C., Finley, L. W. S., Lahusen, T., Souza, A. L., Pierce, K., Li, Y.-H., Wang, X., Laurent, G., German, N. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.024 · Cited by 445
Guan, B., Wang, T., & Shih, I. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1562 · Cited by 453
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
Cazzalini, O., Scovassi, A. I., Savio, M., Stivala, L. A., & Prosperi, E. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.01.009 · Cited by 445
Harnessing the anti-cancer natural product nimbolide for targeted protein degradation
Spradlin, J. N., Hu, X., Ward, C. C., Brittain, S. M., Jones, M. D., Ou, L., To, M., Proudfoot, A., Ornelas, E., Woldegiorgis, M., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0304-8 · Cited by 432
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
Kobayashi, A., Okuda, H., Xing, F., Pandey, P. R., Watabe, M., Hirota, S., Pai, S. K., Liu, W., Fukuda, K., Chambers, C., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110840 · Cited by 440
Examination of the expanding pathways for the regulation of p21 expression and activity
Jung, Y.-S., Qian, Y., & Chen, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.013 · Cited by 428
An overview of Cdk1-controlled targets and processes
Enserink, J. M., & Kolodner, R. D. (2010) · Cell Division · doi:10.1186/1747-1028-5-11 · Cited by 409
The RING 2.0 web server for high quality residue interaction networks
Piovesan, D., Minervini, G., & Tosatto, S. C. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw315 · Cited by 417
Biological and clinical aspects of HPV-related cancers
Szymonowicz, K., & Chen, J. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0370 · Cited by 406
Lehmann, M., Korfei, M., Mutze, K., Klee, S., Skronska-Wasek, W., Alsafadi, H. N., Ota, C., Costa, R., Schiller, H. B., Lindner, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02367-2016 · Cited by 403
Barr, A. R., Cooper, S., Heldt, F. S., Butera, F., Stoy, H., Mansfeld, J., Novák, B., & Bakal, C. (2017) · Nature Communications · doi:10.1038/ncomms14728 · Cited by 403
Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region
Wu, S., Huang, S., Ding, J., Zhao, Y., Liang, L., Liu, T., Zhan, R., & He, X. (2010) · Oncogene · doi:10.1038/onc.2010.34 · Cited by 346
Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing
Vietri, M., Schink, K. O., Campsteijn, C., Wegner, C. S., Schultz, S. W., Christ, L., Thoresen, S. B., Brech, A., Raiborg, C., & Stenmark, H. (2015) · Nature · doi:10.1038/nature14408 · Cited by 393
Moore, N., & Lyle, S. R. (2010) · Journal of Oncology · doi:10.1155/2011/396076 · Cited by 378
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
Ramaiah, M. J., Tangutur, A. D., & Manyam, R. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119504 · Cited by 365
Matoulkova, E., Michalova, E., Vojtesek, B., & Hrstka, R. (2012) · RNA Biology · doi:10.4161/rna.20231 · Cited by 357
Deubiquitinase-targeting chimeras for targeted protein stabilization
Henning, N. J., Boike, L., Spradlin, J. N., Ward, C. C., Liu, G., Zhang, E., Belcher, B. P., Brittain, S. M., Hesse, M. J., Dovala, D., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-00971-2 · Cited by 344
Ceccaldi, R., Parmar, K., Mouly, E., Delord, M., Kim, J. M., Regairaz, M., Pla, M., Vasquez, N., Zhang, Q., Pondarré, C., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.013 · Cited by 359
Shamloo, B., & Usluer, S. (2019) · Cancers · doi:10.3390/cancers11081178 · Cited by 336
Chen, Y., Chiu, W., Chen, Y., Lin, P.-Y., Huang, H., Chou, C.-Y., Chang, H., Tang, M., & Shen, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103315108 · Cited by 327
DNA damage checkpoint kinases in cancer
Smith, H. L., Southgate, H. E. D., Tweddle, D. A., & Curtin, N. J. (2020) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2020.3 · Cited by 328
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Pellarin, I., Dall’Acqua, A., Favero, A., Segatto, I., Rossi, V., Crestan, N., Karimbayli, J., Belletti, B., & Baldassarre, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02080-z · Cited by 381
Ruiz, S., Panopoulos, A. D., Herrerias, A., Bissig, K., Lutz, M. K., Berggren, W. T., Verma, I. M., & Belmonte, J. C. I. (2010) · Current Biology · doi:10.1016/j.cub.2010.11.049 · Cited by 325
Tian, Z., D’Arcy, P., Wang, X., Ray, A., Tai, Y., Hu, Y., Carrasco, R. D., Richardson, P. G. G., Linder, S. T., Chauhan, D., et al. (2013) · Blood · doi:10.1182/blood-2013-05-500033 · Cited by 313
Liu, Z., Sun, M., Lu, K., Liu, J., Zhang, M., Wu, W., De, W., Wang, Z., & Wang, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077293 · Cited by 309
Galanos, P., Vougas, K., Walter, D., Polyzos, A., Maya-Mendoza, A., Haagensen, E. J., Kokkalis, A., Roumelioti, F.-M., Gagos, S., Tzetis, M., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3378 · Cited by 308
Small RNA‐mediated regulation of iPS cell generation
Li, Z., Yang, C., Nakashima, K., & Rana, T. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.2 · Cited by 308
Human Glioma Growth Is Controlled by MicroRNA-10b
Gabriely, G., Yi, M., Narayan, R. S., Niers, J. M., Wurdinger, T., Imitola, J., Ligon, K. L., Kesari, S., Esau, C., Stephens, R. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3568 · Cited by 266
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Kreis, N., Louwen, F., & Yuan, J. (2019) · Cancers · doi:10.3390/cancers11091220 · Cited by 309
Senescence from G2 arrest, revisited
Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300
Sun, M., Jin, F.-Y., Xia, R., Kong, R., Li, J., Xu, T., Liu, Y.-W., Zhang, E., Liu, X.-H., & De, W. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-319 · Cited by 298
Yosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V. (2017) · The EMBO Journal · doi:10.15252/embj.201695553 · Cited by 293
p53 Family and Cellular Stress Responses in Cancer
Pflaum, J., Schlosser, S., & ller, M. M. ⁄. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00285 · Cited by 309
Warfel, N. A., & El‐Deiry, W. S. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835b639e · Cited by 287
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
Huang, W., Chen, T.-Q., Fang, K., Zeng, Z., Ye, H., & Chen, Y.-Q. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01129-8 · Cited by 281
Circadian molecular clocks and cancer
Kelleher, F. C., Rao, A. D., & Maguire, A. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.040 · Cited by 283
Cellular senescence and SASP in tumor progression and therapeutic opportunities
Dong, Z., Luo, Y., Yuan, Z., Tian, Y., Jin, T., & Feng, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02096-7 · Cited by 315
Natural products reveal cancer cell dependence on oxysterol-binding proteins
Burgett, A. W. G., Poulsen, T. B., Wangkanont, K., Anderson, D. R., Kikuchi, C., Shimada, K., Okubo, S., Fortner, K. C., Mimaki, Y., Kuroda, M., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.625 · Cited by 269
p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy
El‐Deiry, W. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2055 · Cited by 268
Cancer and the Circadian Clock
Shafi, A. A., & Knudsen, K. E. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0566 · Cited by 264
The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway
Liu, J., Zhang, C., Wang, J., Hu, W., & Feng, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218387 · Cited by 255
Transcription factors in ferroptotic cell death
Dai, C., Chen, X., Li, J., Comish, P. B., Kang, R., & Tang, D. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-0170-2 · Cited by 244
A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism
Pribluda, A., Elyada, E., Wiener, Z., Hamza, H., Goldstein, R. E., Biton, M., Burstain, I., Morgenstern, Y., Brachya, G., Billauer, H., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.005 · Cited by 239
Dutto, I., Tillhon, M., Cazzalini, O., Stivala, L. A., & Prosperi, E. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1430-4 · Cited by 242
Bcl11a is essential for lymphoid development and negatively regulates p53
Yu, Y., Wang, J., Khaled, W. T., Burke, S., Li, P., Chen, X., Yang, W., Jenkins, N. A., Copeland, N. G., Zhang, S., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121846 · Cited by 223
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
Koster, R., di Pietro, A., Timmer‐Bosscha, H., Gibcus, J. H., van den Berg, A., Suurmeijer, A. J. H., Bischoff, R., Gietema, J. A., & de Jong, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41939 · Cited by 227
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk
Dunlop, M. G., The Swedish Low-Risk Colorectal Cancer Study Group, The COIN Collaborative Group, Dobbins, S. E., Farrington, S. M., Jones, A. M., Palles, C., Whiffin, N., Tenesa, A., Spain, S. L., et al. (2012) · Nature Genetics · doi:10.1038/ng.2293 · Cited by 227
Bitar, S. A., & Gali‐Muhtasib, H. U. (2019) · Cancers · doi:10.3390/cancers11101475 · Cited by 231
ID1 and ID3 Regulate the Self-Renewal Capacity of Human Colon Cancer-Initiating Cells through p21
O'Brien, C. A., Kreso, A., Ryan, P. M., Hermans, K. G., Gibson, L., Wang, Y., Tsatsanis, A., Gallinger, S., & Dick, J. E. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.036 · Cited by 222
Yuan, Y., Zhang, S., Hwang, J.-Y., & Kong, I. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6121328 · Cited by 222
Cell cycle regulation by the intrinsically disordered proteins p21 and p27
Yoon, M., Mitrea, D. M., Li, O., & Kriwacki, R. W. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120092 · Cited by 219
Sanli, T., Rashid, A., Liu, C., Harding, S. M., Bristow, R. G., Cutz, J.-C., Singh, G., Wright, J. R., & Tsakiridis, T. K. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.03.005 · Cited by 216
The p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins
Kim, E. M., Jung, C., Kim, J., Hwang, S., Park, J. K., & Um, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2098 · Cited by 211
Quercetin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells
Ranganathan, S., Devaraj, H., & Sivasithambaram, N. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141370 · Cited by 209
Lachenmayer, A., Toffanin, S., Cabellos, L., Alsinet, C., Hoshida, Y., Villanueva, A., Mínguez, B., Tsai, H. W., Ward, S. C., Thung, S. N., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.009 · Cited by 206
CKIα ablation highlights a critical role for p53 in invasiveness control
Elyada, E., Pribluda, A., Goldstein, R. E., Morgenstern, Y., Brachya, G., Cojocaru, G., Snir-Alkalay, I., Burstain, I., Haffner‐Krausz, R., Jung, S., et al. (2011) · Nature · doi:10.1038/nature09673 · Cited by 202
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194
A unified model for the G1/S cell cycle transition
Hume, S., Dianov, G. L., & Ramadan, K. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1002 · Cited by 207
Sirtuins in metabolism, DNA repair and cancer
Mei, Z., Zhang, X., Yi, J., Huang, J., He, J., & Tao, Y. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0461-5 · Cited by 196
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
Huang, S., Wang, L.-L., Xue, N., Li, C., Guo, H., Ren, T., Zhan, Y., Li, W., Zhang, J., Chen, X., et al. (2019) · Theranostics · doi:10.7150/thno.34674 · Cited by 188
Effects of hyperglycemia on the progression of tumor diseases
Li, W., Zhang, X., Sang, H., Zhou, Y., Shang, C., Wang, Y., & Zhu, H. Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1309-6 · Cited by 188
Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma
Chen, Y., Terajima, M., Yang, Y., Sun, L., Ahn, Y., Paňková, D., Puperi, D. S., Watanabe, T., Kim, M. P., Blackmon, S. H., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74725 · Cited by 186
Nguyen, L. T., Lee, Y., Sharma, A. R., Park, J.-B., Jagga, S., Sharma, G., Lee, S., & Nam, J. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2017.21.2.205 · Cited by 183
Cell Cycle Regulation During Viral Infection
Bagga, S., & Bouchard, M. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_10 · Cited by 187
Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy
Hsu, C.-H., Altschuler, S. J., & Wu, L. F. (2019) · Cell · doi:10.1016/j.cell.2019.05.041 · Cited by 181
Jin, X., Tang, J., Qiu, X., Nie, X., Ou, S., Wu, G., Zhang, R., & Zhu, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01825-7 · Cited by 188
The role of p21 in cellular senescence and aging-related diseases
Yan, J., Chen, S., Yi, Z., Zhao, R., Zhu, J., Shuwen, D., & Wu, J. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100113 · Cited by 188
DNA Damage Response in Plants: Conserved and Variable Response Compared to Animals
Yoshiyama, K., Sakaguchi, K., & Kimura, S. (2013) · Biology · doi:10.3390/biology2041338 · Cited by 182
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21
Chen, H., Li, C., Huang, J., Cung, T. D. H., Seiss, K., Beamon, J., Carrington, M. N., Porter, L. C., Burke, P. S., Yang, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44539 · Cited by 174
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities
Porter, D. C., Farmaki, E., Altilia, S., Schools, G. P., West, D. K., Chen, M., Chang, B.-D., Puzyrev, A. T., Lim, C., Rokow-Kittell, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206906109 · Cited by 177
WAC, a Functional Partner of RNF20/40, Regulates Histone H2B Ubiquitination and Gene Transcription
Zhang, F., & Yu, X. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.024 · Cited by 177
The molecular mechanisms of ferroptosis and its role in cardiovascular disease
Zhang, Y., Xin, L., Xiang, M., Shang, C., Wang, Y., Wang, Y., Cui, X., & Lu, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112423 · Cited by 175
Bi, J., Liu, H., Dong, W., Xie, W., He, Q., Cai, Z., Huang, J., & Lin, T. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1060-9 · Cited by 170
The lauric acid-activated signaling prompts apoptosis in cancer cells
Lappano, R., Sebastiani, A., Cirillo, F., Rigiracciolo, D. C., Galli, G. R., Curcio, R., Malaguarnera, R., Belfiore, A., Cappello, A. R., & Maggiolini, M. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.63 · Cited by 169
Regulation of senescence traits by MAPKs
Anerillas, C., Abdelmohsen, K., & Gorospe, M. (2020) · GeroScience · doi:10.1007/s11357-020-00183-3 · Cited by 172
Protein and its function based on a subcellular localization
Ćmielová, J., & Řezáčová, M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23296 · Cited by 170
Dysregulation of cellular signaling in gastric cancer
Wu, W. K. K., Cho, C. H., Lee, C. W., Fan, D., Wu, K., Yu, J. Q., & Sung, J. J. �. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.025 · Cited by 165
Deng, T., Yan, G., Song, X., Xie, L. Y., Zhou, Y., Li, J., Hu, X., Li, Z., Hu, J., Zhang, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714938115 · Cited by 162
Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates?
Coverdale, J. P. C., Laroiya-McCarron, T., & Romero‐Canelón, I. (2019) · Inorganics · doi:10.3390/inorganics7030031 · Cited by 169
TGF-β signaling: critical nexus of fibrogenesis and cancer
Giarratana, A. O., Prendergast, C. M., Salvatore, M. M., & Capaccione, K. M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05411-4 · Cited by 180
MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
Zheng, L., Zhang, Y., Liu, Y., Zhou, M., Lu, Y., Li, Y., Zhang, C., Hong, M., Wang, S., & Li, X. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0592-z · Cited by 159
A Human Herpesvirus MicroRNA Inhibits p21 Expression and Attenuates p21-Mediated Cell Cycle Arrest
Gottwein, E., & Cullen, B. R. (2010) · Journal of Virology · doi:10.1128/jvi.00202-10 · Cited by 161
Metadata
- Authors
- Abbas, T., & Dutta, A.
- Affiliations
- University of Virginia (US)
- Corresponding author
- Abbas, Tarek
- Dutta, Anindya
- Venue
- Nature Reviews Cancer
- Published
- 2009-05-14
- Volume
- 9
- Issue
- 6
- Pages
- 400-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2722839
- OpenAlex
- W2162262059
- Cited by
- 2,712
- References
- 236
- Citations by year
- 2026: 99 · 2025: 156 · 2024: 161 · 2023: 206 · 2022: 182 · 2021: 205 · 2020: 204 · 2019: 180 · 2018: 191 · 2017: 196 · 2016: 148 · 2015: 160 · 2014: 142 · 2013: 151 · 2012: 122
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA089406, R01 CA 89406, T32CA009109)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- p21, cyclin-dependent kinase inhibitors, cell cycle arrest, therapeutic target, cell transformation
- MeSH terms
- Animals, Cell Cycle, Humans, Neoplasms, Tumor Suppressor Protein p53, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
